The Veracity Biolabs teams are recognized experts

in the Australian Clinical Trials Network, with proven track record in key therapeutic areas.

Veracity Biolabs provides a full suite of laboratory testing solutions in a wide range of therapeutic areas with a strong focus in oncology, infectious diseases and vaccines.

Benefit from a consultative approach
aligned with your study unique requirements.
Clinical drug development in immunology, vaccines and immuno-oncology requires commitment, innovative approaches and dedicated experts working closely with your organisation.
  • Our broad capabilities and expertise enable us to offer our sponsors the additional benefit of working with a single outsourcing provider.
  • PBMC processing and sample aliquoting
  • Cytokine testing- design of customised panels and pre-validated panels i.e. Th1, Th2, Th17, Inflammatory panels, etc
  • ELISA based assays- including ELISA custom kit development (as part of
  • Flow cytometry- custom and validated panels, receptor occupancy assays (RO)
  • Biomarker analysis by FACS to evaluate activation of specific sub-populations such as T, B, NK, Tregs, DCs, etc
Clinical Genomics
Comprehensive clinical genomics expertise,
accelerating the development of targeted medicine.
Personalised medicine is driving more precise and powerful healthcare. The use of clinical genomics is enabling doctors to tailor medical treatment to the individual characteristics of each patient.
  • Integrated suite of genomics services to accelerate the development of tailored healthcare to each person’s unique genetic background.
  • DNA/RNA extraction
  • Design of customised SNP panels
  • Pharmacogenomics genotype service- custom assay design or pre-validated panels
  • Quantitive PCR, RT-PCR
  • NanoString
  • MassARRAY System (Agena BioScience)
  • Next-generation sequencing (NGS)
  • Other technologies are also available through our extensive laboratory network.
Virology, Vaccines & Immunotherapies
Explore our end-to-end virology
and vaccines capabilities.
Veracity biolabs founders are worldwide experts with strong expertise developing vaccines. We offer a comprehensive suite of laboratory assays supported by experienced virologists and immunologists.
  • We are committed to advancing public health. To characterise newly designed vaccine candidates and immunotherapies we offer a range of functional assays tailored to each specific indication.
  • Neutralization assays (HAI, PRNT, IFA, microneutralisation, agarose overlay etc) for a range of viruses including HIV, Lassa, Marburg, Nipah, DEN1,2,3,4, Zika virus, HBV, Flu, RSV, CHIKV
  • Viral load determination by cell culture, cytopathic effect, TCID50
  • q-PCR, RT-PCR
  • Cell based-assays for MoA analysis, i.e. ADE assays (Dengue and Zika)
  • Characterization of CD4+ and CD8+ T cell responses by intracellular cytokine staining (ICS)
  • IHC incl. PD-L1, FISH Access to BSL3 and BSL4 cutting edge facilities
  • Other technologies are also available through our extensive laboratory network
Kits & Logistics
Custom solutions
for early stage clinical studies.
Based on the study protocol details, we handle preparation of sample collection kits tailored for each clinical trial ensuring that clinical studies are conducted smoothly at the sites.
  • Our team works closely with the clinical research organizations managing the studies and the clinical sites to ensure timely testing and optimal turnaround time.
  • Sample collection kit building & laboratory manual
  • Bio-banking
  • Sample logistics
  • Consultancy services also available